An Open-label, Proof of Concept Study of Gevokizumab in

Project: Research project

Project Details

Description

An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum
StatusFinished
Effective start/end date6/15/136/15/14

Funding

  • XOMA Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.